[Cardiac transplantation]

Kazuhiro Yamamoto1, Seiji Takashima, Tohru Masuyama

  • 1Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine.

Insights

Cardiac transplantation is a vital treatment for end-stage heart failure. While established globally, Japan faces challenges in increasing the number of these life-saving procedures despite initial success.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Medical Ethics

Context:

  • Cardiac transplantation is a recognized treatment for end-stage heart failure in developed nations.
  • Japan's first cardiac transplant under new legislation occurred in February 1999.
  • Post-legislation, there was initial progress in obtaining consent for brain-dead donor transplants.

Purpose:

  • To review the status of cardiac transplantation in Japan following the 1999 legislation.
  • To highlight the need for increased cardiac transplantations in Japan.
  • To advocate for cardiac transplantation as a standard therapy for heart failure.

Summary:

  • The first Japanese cardiac transplant occurred in 1999, with subsequent improvements in consent for brain-dead donors.
  • However, the volume of cardiac transplantations in Japan remained insufficient in the following three years.
  • This indicates a need for further development and expansion of the program.

Impact:

  • Increased cardiac transplant rates could establish it as a mainstream therapy for heart failure in Japan.
  • Broader acceptance and implementation of cardiac transplantation can save more lives.
  • Further research and policy adjustments may be needed to overcome barriers to transplantation.